stockrowIntuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Shares outstanding
Intuitive Surgical, Inc.'s shares outstanding at the end of fiscal 2025 was $362.7M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $351.6M. Over the past ten years it has ranged from $341.1M (fiscal 2015) to $365.8M (fiscal 2021); the current reading is higher than 91% of that period. Intuitive Surgical, Inc. ranks 6th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $362.7M | 0.19% |
| FY2024 | $362.0M | 1.29% |
| FY2023 | $357.4M | (1.27%) |
| FY2022 | $362.0M | (1.04%) |
| FY2021 | $365.8M | 1.33% |
| FY2020 | $361.0M | 0.73% |
| FY2019 | $358.4M | 0.56% |
| FY2018 | $356.4M | 2.15% |
| FY2017 | $348.9M | (1.36%) |
| FY2016 | $353.7M | 3.69% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $351.6M | (1.60%) |
| Jun 2026 | $357.3M | (0.69%) |
| Mar 2026 | $359.8M | (0.80%) |
| Dec 2025 | $362.7M | 0.25% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $1.3B |
| BAX Baxter International Inc. compare | $520.0M |
| ALC Alcon compare | $488.7M |
| ISRG Intuitive Surgical, Inc. | $351.6M |
| BDX Becton, Dickinson and Company compare | $275.2M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $170.8M |
| RMD ResMed Inc. compare | $143.4M |
| WST West Pharmaceutical Services, Inc. compare | $70.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement